Shares of Entrada Therapeutics Inc. trade on the NASDAQ stock exchange under the ticker symbol TRDA at approximately $7.58 per share. Intraday equity valuations shift continuously during active trading sessions in response to biotechnology sector sentiment, clinical trial announcements, institutional portfolio adjustments, and broader macroeconomic conditions impacting small-cap healthcare equities.